Bipolar Depression and Riluzole
Join a Research Study: Bipolar Disorder
To find out if you qualify, email NIMH or call 1-877-646-3644 (1-877-MIND-NIH) [TTY: 1-866-411-1010].
This research study is enrolling eligible participants, ages 18-70, with Bipolar Depression whose depressive symptoms have failed to improve. The study is evaluating how riluzole (an FDA approved drug for ALS, Lou Gehrig's disease) vs. placebo affects glutamate in the brain and whether a rapid improvement in symptoms may occur.
This is an 8-week study conducted at the NIH Clinical Center in Bethesda, Maryland. There is no cost to participate and compensation is provided. We enroll participant locally and from around the country. Travel arrangements provided and costs covered by NIMH. (Arrangements vary by distance and by specific study.) After completing the study participants receive short-term follow-up care while transitioning back to a provider. Atendemos pacientes de habla hispana.
Call about your eligibility to participate.